Propiedad y actividad de insiders de Enlivex Therapeutics Ltd. (ENLV): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.81 |
| Capitalización | $14M |
| Bolsa | NASDAQ |
| País | IL |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $6.9M | $3.5M | $9.7M | $3.9M | $5.7M | $11.2M | $49.9M | $813000 | $3.3M | $2.0M |
| Inversiones a Corto | $3.0M | 0 | $40000 | $8.1M | $30.0M | $72.9M | $299000 | $26.5M | $20.2M | $3.9M |
| Cuentas por Cobrar | $52000 | $28000 | $213000 | $2.4M | $1.2M | $1.1M | $647000 | $229000 | $1.3M | $235000 |
| Inventario | 0 | 0 | 0 | $1.5M | 0 | 0 | $1.2M | 0 | 0 | 0 |
| Activos Corrientes | $10.5M | $3.6M | $10.3M | $16.4M | $38.1M | $86.4M | $52.3M | $33.8M | $26.0M | $1.74B |
| Inmovilizado Material | $71000 | $388 | $685000 | $1.1M | $2.1M | $8.2M | $14.9M | $2.6M | $1.2M | $938000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $410000 | 0 | 0 | 0 | 0 | 0 | $582.5M |
| Activos Totales | $10.6M | $3.6M | $11.0M | $17.6M | $40.4M | $95.1M | $67.6M | $36.8M | $27.7M | $2.33B |
| Cuentas por Pagar | $32000 | $19000 | $173000 | $316000 | $463000 | $878000 | $1.9M | $827000 | $811000 | $3.8M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $653000 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.9M | $460000 | $1.1M | $6.0M | $4.4M | $4.7M | $6.6M | $6.1M | $3.8M | $9.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.9M | $460000 | $1.3M | $6.3M | $4.9M | $10.1M | $10.8M | $6.7M | $4.1M | $392.1M |
| Reservas | -$39.8M | -$45.8M | -$16.3M | -$25.7M | -$37.5M | -$52.0M | -$83.0M | -$112.1M | -$127.1M | $1.11B |
| Patrimonio Neto | $8.7M | $3.2M | $9.7M | $11.3M | $35.5M | $85.0M | $56.8M | $30.1M | $23.6M | $1.93B |
| Deuda Total | 0 | 0 | 0 | $123000 | $203000 | $6.0M | $4.8M | $1.0M | $534000 | $641000 |
| Deuda Neta | -$9.9M | -$3.5M | -$9.8M | -$11.9M | -$35.5M | -$78.1M | -$45.4M | -$26.3M | -$23.1M | -$5.2M |
| Capital Circulante | $8.6M | $3.2M | $9.1M | $10.4M | $33.7M | $81.7M | $45.7M | $27.7M | $22.2M | $1.73B |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 193.24 |
Rentabilidad
| Rentabilidad sobre capital | 248.08% |
| Rentabilidad sobre capital invertido | -0.49% |
| Rentabilidad sobre activos | 53.10% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: CLGN · CVKD · GDTC · LSTA · MTVA · NCNA · NRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de ENLV: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones